HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$13.88
Day range
$13.21 - $13.87
Year range
$8.24 - $18.37
Market cap
862.21M USD
Avg Volume
1.91M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 51.77M | 86.81% |
Net income | -48.95M | -100.69% |
Net profit margin | — | — |
Earnings per share | -0.98 | -60.66% |
EBITDA | -51.75M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 198.19M | -16.22% |
Total assets | 205.90M | -18.17% |
Total liabilities | 14.65M | 39.73% |
Total equity | 191.26M | — |
Shares outstanding | 49.84M | — |
Price to book | 3.61 | — |
Return on assets | -54.59% | — |
Return on capital | -60.45% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -48.95M | -100.69% |
Cash from operations | -66.84M | -130.64% |
Cash from investing | 83.57M | 1,133.13% |
Cash from financing | 90.00K | 21.62% |
Net change in cash | 16.82M | 145.46% |
Free cash flow | -48.92M | -146.48% |
About
Founded
2019
Website
Employees
51
